Mariner’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Buy
240,888
+77,558
+47% +$6.91M 0.02% 464
2025
Q4
$12.9M Sell
163,330
-49,133
-23% -$3.85M 0.02% 590
2025
Q3
$17M Sell
212,463
-62,122
-23% -$5.3M 0.02% 463
2025
Q2
$24.9M Buy
274,585
+2,407
+0.9% +$220K 0.04% 358
2025
Q1
$25.5M Sell
272,178
-4,906
-2% -$439K 0.04% 332
2024
Q4
$25.2M Sell
277,084
-623
-0.2% -$59.5K 0.04% 320
2024
Q3
$28.8M Buy
277,707
+14,359
+5% +$1.46M 0.05% 289
2024
Q2
$25.6M Buy
263,348
+8,605
+3% +$794K 0.05% 298
2024
Q1
$22.9M Buy
254,743
+4,335
+2% +$367K 0.05% 304
2023
Q4
$20M Buy
250,408
+3,516
+1% +$264K 0.05% 306
2023
Q3
$17.6M Buy
246,892
+12,634
+5% +$945K 0.05% 311
2023
Q2
$18M Buy
234,258
+19,414
+9% +$1.5M 0.05% 315
2023
Q1
$16.1M Sell
214,844
-15,253
-7% -$1.13M 0.05% 326
2022
Q4
$18.1M Buy
230,097
+48,028
+26% +$3.6M 0.06% 293
2022
Q3
$12.8M Sell
182,069
-810
-0.4% -$63.5K 0.05% 302
2022
Q2
$14.7M Buy
182,879
+10,853
+6% +$849K 0.06% 264
2022
Q1
$13M Buy
172,026
+52,656
+44% +$4.17M 0.05% 301
2021
Q4
$10.2M Buy
119,370
+53,987
+83% +$4.22M 0.04% 305
2021
Q3
$4.94M Buy
65,383
+4,197
+7% +$333K 0.03% 364
2021
Q2
$4.98M Sell
61,186
-1,685
-3% -$138K 0.03% 330
2021
Q1
$4.96M Buy
62,871
+936
+2% +$73.4K 0.03% 312
2020
Q4
$5.3M Sell
61,935
-2,385
-4% -$197K 0.04% 283
2020
Q3
$4.96M Buy
64,320
+9,441
+17% +$720K 0.05% 263
2020
Q2
$4.02M Sell
54,879
-653
-1% -$46.4K 0.04% 286
2020
Q1
$3.69M Buy
55,532
+4,142
+8% +$292K 0.05% 279
2019
Q4
$3.54M Buy
51,390
+1,373
+3% +$93.6K 0.04% 308
2019
Q3
$3.68M Buy
50,017
+3,789
+8% +$275K 0.04% 281
2019
Q2
$3.31M Buy
46,228
+1,133
+3% +$80.4K 0.04% 313
2019
Q1
$3.09M Buy
45,095
+1,401
+3% +$90.5K 0.04% 306
2018
Q4
$2.6M Buy
43,694
+8,148
+23% +$510K 0.05% 291
2018
Q3
$2.38M Sell
35,546
-1,117
-3% -$74.4K 0.06% 262
2018
Q2
$2.38M Buy
36,663
+7,031
+24% +$460K 0.07% 251
2018
Q1
$2.12M Sell
29,632
-2,275
-7% -$164K 0.08% 217
2017
Q4
$2.41M Buy
31,907
+9,764
+44% +$713K 0.09% 183
2017
Q3
$1.61M Buy
22,143
+3,527
+19% +$254K 0.07% 200
2017
Q2
$1.38M Sell
18,616
-1,447
-7% -$107K 0.06% 211
2017
Q1
$1.47M Sell
20,063
-34,747
-63% -$2.43M 0.06% 226
2016
Q4
$3.59M Sell
54,810
-3,872
-7% -$265K 0.17% 118
2016
Q3
$4.35M Buy
58,682
+2,801
+5% +$207K 0.21% 91
2016
Q2
$4.09M Buy
55,881
+1,040
+2% +$74.1K 0.22% 99
2016
Q1
$3.88M Buy
54,841
+6,172
+13% +$411K 0.23% 90
2015
Q4
$3.24M Buy
48,669
+5,136
+12% +$342K 0.21% 105
2015
Q3
$2.76M Buy
43,533
+1,571
+4% +$103K 0.12% 148
2015
Q2
$2.75M Buy
41,962
+4,427
+12% +$300K 0.13% 145
2015
Q1
$2.6M Buy
37,535
+1,042
+3% +$72K 0.22% 85
2014
Q4
$2.52M Buy
36,493
+6,337
+21% +$428K 0.23% 82
2014
Q3
$1.97M Buy
30,156
+397
+1% +$26.2K 0.22% 80
2014
Q2
$2.03M Buy
29,759
+94
+0.3% +$6.3K 0.23% 86
2014
Q1
$1.92M Buy
29,665
+330
+1% +$20.8K 0.25% 85
2013
Q4
$1.91M Sell
29,335
-204
-0.7% -$13.1K 0.24% 88
2013
Q3
$1.75M Sell
29,539
-957
-3% -$56.7K 0.32% 78
2013
Q2
$1.75M Buy
+30,496
New +$1.81M 0.37% 70

Other funds holding CL

Mariner's CL Position: Q1 2026 in Review

Mariner increased its Colgate-Palmolive (CL) stake by 47% in Q1 2026, buying an estimated $6.91M and bringing the position to 240,888 shares worth $20.5M. The position accounts for 0.02% of the portfolio, ranked #464.

Mariner first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.8M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Mariner held 240,888 shares of Colgate-Palmolive worth $20.5M as of Q1 2026.
  • Mariner bought 77,558 Colgate-Palmolive shares in Q1 2026, an estimated $6.91M.
  • Colgate-Palmolive made up 0.02% of Mariner's portfolio in Q1 2026, its #464 holding.
  • Mariner first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Mariner's Colgate-Palmolive position peaked at $28.8M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.